DK2089371T3 - Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL - Google Patents

Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL

Info

Publication number: DK2089371T3
Authority: DK; Denmark
Prior art keywords: hexahydrofuro; furan; preparation; preparing; methods
Prior art date: 2006-11-09

Application number

DK07822416.9T

Other languages

English (en)

Inventor

Sebastien Francois Emmanuel Lemaire

Andras Horvath

Wim Albert Alex Aelterman

Thomas Joachim Landewald Rammeloo

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-09

Filing date

2007-11-09

Publication date

2011-05-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37692659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2089371(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-11-09 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2011-05-16 Application granted granted Critical

2011-05-16 Publication of DK2089371T3 publication Critical patent/DK2089371T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Furan Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

DK07822416.9T 2006-11-09 2007-11-09 Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL DK2089371T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06123752		2006-11-09
PCT/EP2007/062119 WO2008055970A2 (en)	2006-11-09	2007-11-09	Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol

Publications (1)

Publication Number	Publication Date
DK2089371T3 true DK2089371T3 (da)	2011-05-16

Family

ID=37692659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07822416.9T DK2089371T3 (da)	2006-11-09	2007-11-09	Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL

Country Status (22)

Country	Link
US (1)	US8153829B2 (da)
EP (1)	EP2089371B1 (da)
JP (1)	JP5491862B2 (da)
CN (2)	CN101541775B (da)
AT (1)	ATE497499T1 (da)
AU (1)	AU2007316562B2 (da)
BR (1)	BRPI0718706B8 (da)
CA (1)	CA2669014C (da)
CY (1)	CY1111407T1 (da)
DE (1)	DE602007012365D1 (da)
DK (1)	DK2089371T3 (da)
ES (1)	ES2359949T3 (da)
HR (1)	HRP20110258T1 (da)
IL (1)	IL198270A (da)
ME (1)	ME01232B (da)
MX (1)	MX2009004957A (da)
PL (1)	PL2089371T3 (da)
PT (1)	PT2089371E (da)
RS (1)	RS51675B (da)
RU (1)	RU2464266C2 (da)
SI (1)	SI2089371T1 (da)
WO (1)	WO2008055970A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010075887A1 (en) *	2008-12-30	2010-07-08	Oxyrane (Uk) Limited	Methods and intermediates useful in the synthesis of hexahydrofuro[2,3-b]furan-3-ol
US8921415B2 (en)	2009-01-29	2014-12-30	Mapi Pharma Ltd.	Polymorphs of darunavir
US9062065B2 (en)	2009-10-30	2015-06-23	Lupin Limited	Process for preparation of darunavir and darunavir ethanolate of fine particle size
US20110313035A1 (en)	2009-12-16	2011-12-22	Hetero Research Foundation	Polymorphs of darunavir
ES2516916T3 (es)	2010-01-28	2014-10-31	Mapi Pharma Limited	Procedimiento para la preparación de darunavir e intermedios de darunavir
US8853430B2 (en)	2010-05-20	2014-10-07	Hetero Research Foundation	Crystalline hydrochloride salt of darunavir
CN102617586B (zh) *	2011-01-26	2016-04-06	浙江九洲药业股份有限公司	地瑞那韦中间体的制备方法
EP2887807B1 (en)	2012-08-22	2019-09-18	Merck Sharp & Dohme Corp.	Benzimidazole hexahydrofuro[3,2-b]furan derivatives useful as amp-activated protein kinase activators
CN103864813B (zh) *	2012-12-18	2017-02-22	上海迪赛诺化学制药有限公司	一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
CN103896886A (zh) *	2012-12-31	2014-07-02	上海迪赛诺化学制药有限公司	一种达鲁那韦中间体及其制备方法和应用
TW201514188A (zh) *	2013-03-13	2015-04-16	Lantheus Medical Imaging Inc	製備釓磷維塞三鈉單水合物之方法
CN103664976B (zh) *	2013-12-12	2015-11-04	惠州市莱佛士制药技术有限公司	一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
CN107344944B (zh) *	2016-05-07	2021-03-05	成都博腾药业有限公司	一种制备地瑞那韦中间体的方法
CN112300186B (zh) *	2019-08-01	2024-04-30	浙江九洲药业股份有限公司	六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE174587T1 (de)	1993-08-24	1999-01-15	Searle & Co	Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
DE69512220T2 (de)	1994-03-07	2000-03-16	Vertex Pharmaceuticals Inc.	Sulfonamidderivate als aspartylprotease-inhibitoren
JP3665343B2 (ja)	1995-02-03	2005-06-29	株式会社カネカ	α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法
CA2236236A1 (en)	1995-11-15	1997-05-22	G.D. Searle & Co.	Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5856531A (en) *	1996-10-21	1999-01-05	Eastman Chemical Company	Preparation of 3-methytetra-hydrofuran from 2,3-dihydrofuran
JP2002515888A (ja) *	1996-10-21	2002-05-28	イーストマンケミカルカンパニー	３―アルキルテトラヒドロフランの製造方法
US5990313A (en) *	1996-10-21	1999-11-23	Eastman Chemical Company	Preparation of 3-alkyltetrahydrofurans
PT1086076E (pt)	1998-06-19	2005-05-31	Vertex Pharma	Inibidores de sulfonamida de aspartil protease
WO1999067254A2 (en)	1998-06-23	1999-12-29	The United States Of America Represented By The Secretary, Department Of Health And Human Services	Multi-drug resistant retroviral protease inhibitors and use thereof
ES2362404T5 (es)	1998-06-23	2015-11-25	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Ensayo de aptitud y métodos para reducir la resistencia del VIH a terapia
ATE269314T1 (de)	1998-08-25	2004-07-15	Kaneka Corp	Verfahren zur herstellung von (2r, 3s)-amino-1,2- oxiran
US6344572B1 (en)	1999-01-29	2002-02-05	Kaneka Corporation	Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
WO2000047551A2 (en)	1999-02-12	2000-08-17	Vertex Pharmaceuticals Incorporated	Inhibitors of aspartyl protease
AR031520A1 (es)	1999-06-11	2003-09-24	Vertex Pharma	Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
KR100708221B1 (ko)	1999-08-31	2007-04-17	아지노모토 가부시키가이샤	에폭사이드 결정의 제조방법
PL204924B1 (pl)	1999-10-06	2010-02-26	Tibotec Pharm Ltd	Heksahydrofuro [2,3-b] furanylo-3-N-{3(1,3-benzodioksolilo-5-sulfonylo) (izobutylo) amino] -1-benzylo-2-hydroksypropylo} karbaminian oraz jego zastosowanie
WO2002067239A2 (en)	2000-10-24	2002-08-29	Glaxo Group Limited	Process for preparing intermediates of hiv protease inhibitors
KR20020046948A (ko)	2000-12-12	2002-06-21	에가시라 구니오	에폭사이드 결정의 제조방법
CN100519561C (zh) *	2001-09-10	2009-07-29	泰博特克药品有限公司	制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
ATE335745T1 (de)	2001-09-20	2006-09-15	Smithkline Beecham Corp	Verfahren zur herstellung von protease hemmenden zwischenprodukten
SI2314591T2 (sl) *	2002-05-16	2021-08-31	Janssen Sciences Ireland Unlimited Company	Psevdopolimorfne oblike zaviralca HIV proteaze
ES2268427T3 (es)	2002-06-27	2007-03-16	Smithkline Beecham Corporation	Preparacion de estereoisomeros de (3alfa, 3alfa/beta, 6alfa/beta) hexahidrofuro(2,3-b)furan-3-ol.
AU2003287038A1 (en)	2002-10-09	2004-05-04	The Board Of Trustees Of The University Of Illinois	METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO (2, 3-b) FURAN AND RELATED COMPOUNDS
AU2003275675A1 (en)	2002-12-27	2004-07-29	Sumitomo Chemical Company, Limited	Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
KR101192859B1 (ko) *	2003-12-23	2012-10-19	얀센 알 앤드 디 아일랜드	（3ｒ,3ａｓ,6ａｒ）-헥사하이드로푸로〔2,3-ｂ〕푸란-3-일（1ｓ,2ｒ）-3-〔〔（4-아미노페닐）설포닐〕（이소부틸）아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법
TWI383975B (zh)	2004-03-31	2013-02-01	悌柏泰克醫藥有限公司	製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法

2007
- 2007-11-09 AT AT07822416T patent/ATE497499T1/de active
- 2007-11-09 CA CA2669014A patent/CA2669014C/en active Active
- 2007-11-09 PL PL07822416T patent/PL2089371T3/pl unknown
- 2007-11-09 RS RS20110169A patent/RS51675B/sr unknown
- 2007-11-09 JP JP2009535738A patent/JP5491862B2/ja active Active
- 2007-11-09 RU RU2009121792/04A patent/RU2464266C2/ru active
- 2007-11-09 HR HR20110258T patent/HRP20110258T1/hr unknown
- 2007-11-09 PT PT07822416T patent/PT2089371E/pt unknown
- 2007-11-09 AU AU2007316562A patent/AU2007316562B2/en active Active
- 2007-11-09 EP EP07822416A patent/EP2089371B1/en active Active
- 2007-11-09 MX MX2009004957A patent/MX2009004957A/es active IP Right Grant
- 2007-11-09 US US12/447,537 patent/US8153829B2/en active Active
- 2007-11-09 DE DE602007012365T patent/DE602007012365D1/de active Active
- 2007-11-09 DK DK07822416.9T patent/DK2089371T3/da active
- 2007-11-09 SI SI200730567T patent/SI2089371T1/sl unknown
- 2007-11-09 WO PCT/EP2007/062119 patent/WO2008055970A2/en not_active Ceased
- 2007-11-09 ME MEP-2011-65A patent/ME01232B/me unknown
- 2007-11-09 ES ES07822416T patent/ES2359949T3/es active Active
- 2007-11-09 CN CN2007800418345A patent/CN101541775B/zh active Active
- 2007-11-09 CN CN201110342987.1A patent/CN102432621B/zh active Active
- 2007-11-09 BR BRPI0718706A patent/BRPI0718706B8/pt active IP Right Grant
2009
- 2009-04-21 IL IL198270A patent/IL198270A/en active IP Right Grant
2011
- 2011-05-02 CY CY20111100423T patent/CY1111407T1/el unknown

Also Published As

Publication number	Publication date
CA2669014A1 (en)	2008-05-15
DE602007012365D1 (de)	2011-03-17
BRPI0718706B1 (pt)	2021-03-23
RU2009121792A (ru)	2010-12-20
PL2089371T3 (pl)	2011-06-30
AU2007316562B2 (en)	2013-02-21
PT2089371E (pt)	2011-04-18
IL198270A0 (en)	2009-12-24
CN101541775B (zh)	2011-12-28
BRPI0718706B8 (pt)	2021-05-25
US20100094028A1 (en)	2010-04-15
ES2359949T3 (es)	2011-05-30
WO2008055970A3 (en)	2008-06-26
ATE497499T1 (de)	2011-02-15
CY1111407T1 (el)	2015-08-05
MX2009004957A (es)	2009-05-19
WO2008055970A2 (en)	2008-05-15
IL198270A (en)	2014-02-27
RU2464266C2 (ru)	2012-10-20
RS51675B (sr)	2011-10-31
CN101541775A (zh)	2009-09-23
EP2089371B1 (en)	2011-02-02
AU2007316562A1 (en)	2008-05-15
CN102432621A (zh)	2012-05-02
BRPI0718706A2 (pt)	2014-01-07
CN102432621B (zh)	2016-02-17
HRP20110258T1 (hr)	2011-05-31
SI2089371T1 (sl)	2011-05-31
US8153829B2 (en)	2012-04-10
EP2089371A2 (en)	2009-08-19
JP5491862B2 (ja)	2014-05-14
JP2010509290A (ja)	2010-03-25
CA2669014C (en)	2016-01-26
ME01232B (me)	2013-06-20

Publication	Publication Date	Title
DK2089371T3 (da)	2011-05-16	Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL
IL194122A (en)	2016-08-31	Process for making (6ar, 3as, 3r) hexahydroporo [3,2– b] furan – 3 – val
IL211191A (en)	2015-07-30	Oxalate salt of (3as, 4r, 6s, 6ar) –6– (2– hydroxyethoxy) –2,2 – dimethyl tetrahydro –3 ah– cyclopenta [d] [1,3] dioxol – 4 – amine
EA200700974A1 (ru)	2007-10-26	Способ получения хиральных 8-(3-аминопиперидин-1-ил)ксантинов
CY1119150T1 (el)	2018-01-10	ΜΕΘΟΔΟΙ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ (3R,3aS,6aR) ΕΞΑΫΔΡΟ-ΦΟΥΡΟ[2,3-b]ΦΟΥΡΑΝ-3-ΟΛΗΣ
MX2022008904A (es)	2022-08-16	Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
WO2010077740A3 (en)	2010-09-23	Novel antiviral compounds, compositions, and methods of use
DK1448567T3 (da)	2010-04-26	Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol
WO2008083950A3 (de)	2008-10-16	Spirocyclische tetronsäure-derivative
WO2007076116A3 (en)	2007-11-22	Intermediates for preparing solifenacin
SMT201500309B (it)	2016-01-08	Procedimento per la preparazione di benzil [(3as,4r,6s,6ar)-6-idrossi-2,2-dimetiltetraidro-3ahciclopenta[d][1,3]diossol]-4-il]carbammato ed intermedi nel procedimento
DK2004670T3 (da)	2010-05-03	Fremgangsmåde til fremstilling af lysobactin-derivater
WO2009042853A3 (en)	2010-07-01	Fluorinated oxy-carboxylic acids, derivatives, and methods of preparation
PT2643326T (pt)	2016-12-23	Processo para a preparação de (3r,3as,6ar)-hexa-hidrofuro[2,3-b]furan-3-ol
WO2009085828A3 (en)	2009-09-24	Quinine sulfate polymorphs, processes of preparing, compositions and uses thereof
EA200970406A1 (ru)	2009-10-30	СПОСОБ ПОЛУЧЕНИЯ 5-АЛКИЛ-7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-2-ОЛОВ
WO2010151476A3 (en)	2011-04-21	Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
FI20051058L (fi)	2007-04-22	Menetelmä puhtaiden enantiomeerien valmistukseen
WO2012075122A3 (en)	2014-04-03	Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans